PD-L1 is a B7-related protein that inhibits cell-mediated immune responses by reducing the secretion of IL-2 and IL-10 from memory T cells. PD-L1 can bind to PD-1, which mediates inhibitory signals from the APC. ProSci Inc. offers an extensive range
PD-1 Immune Checkpoint
The PD-1 protein is a negative co-stimulatory receptor that can bind two different but related ligands, PD-L1 and PD-L2. Upon binding, signals generated by PD-1 inhibit the activation of the immune response in the absence of “danger signals.” ProSci Inc.
News Release Research Poster Presented at the New Jersey Cancer Retreat for New Cancer Serum Biomarker Panel
Biotech Support Group presented a poster describing a biomarker panel of cancer dysregulation derived from serum proteomic profiles, at the New Jersey Cancer Retreat held on May 25, 2017 in New Brunswick, NJ. The poster authors and title are: Haiyan
February 2017: The Antibody Update
Epidermal Levels of Staphylococcus Aureus Are Affected by a Peptide Produced by Other Skin Dwelling Bacteria Staphylococcus aureus is common to many of people’s ski n microbiome, and is generally harmless; however, in high population density the bacteria can lead to atopic
November 2016: The Antibody Update
China Perform First Injection of CRISPR Modified Cells into a Person Use of CRISPR-Cas9 in human cells for treatment of disease has been a controversial topic amongst scientists since the discovery of the powerful gene editing tool. In this clinical
QuickSwitch™ – Quickly Create Custom Tetramers
Fast, High-Quality Generation of New Tetramer Specificities Rapid, high-quality creation of custom class I tetramers is now a reality! Create new specificity tetramers in just a few hours with QuickSwitch™ from MBL International; a proprietary technology for exchanging peptides on
The Antibody Basics Series: Table of Contents
ProSci’s the Antibody Basics are a planned series of blogs designed to teach the science behind antibody development, and to serve as a buyers guide to assure that we develop the perfect product for your project. Not too long ago,
August 2016: The Antibody Update from ProSci
ProSci’s top news picks for August 2016 include a study on T-cell activity inside tumor tissue, the potential effects of Zika virus in adults, and mRNA therapeutics. T-cells Run
June 2016: The Antibody Update from ProSci
This months ProSci Antibody Update’s news includes the first CRISPR/Cas9 cancer therapeutic’s entry into clinical trials, how mosquito saliva assists viruses in proliferation, and the latest update on antibody validation. First CRISPR/Cas9 Therapeutic Clinical Trials StartingProSci Blog Antibody UpdateCRISPR Cas9
“Let’s Make America the Country That Cures Cancer Once and For All”
During the 2016 State of the Union Address, President Obama called attention to a myriad of issues currently plaguing Americans. One of the many initiatives President Obama announced in response was a “moonshot” to cure cancer, referencing the flood of